Development and Application of Antibody Against Small Molecule Phytoproduct
A special issue of Antibodies (ISSN 2073-4468).
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 7431
Special Issue Editors
Interests: monoclonal antibodies; bioactive compounds; marihuana study; isolation and structure elucidation; biotechnology.
Interests: natural products; monoclonal antibodies; Kampo; medicinal plants
Special Issue Information
Dear Colleagues,
A Special Issue related to monoclonal antibodies will be published in Antibodies. The research area includes monoclonal antibodies against natural products with a small molecule such as saponins, alkaloids, phenolics, terpenoids, and so on. Furthermore, work exploring the compact antibody and single-chain Fv is also welcome. This Special Issue will be an opportunity to discuss future developments in natural product research.
Antibodies has launched a Special Issue Development and Application of Monoclonal Antibodies Against Small-Molecule Phytoproducts to spread and innovate natural product research using monoclonal antibodies. Monoclonal antibodies against small-molecule natural products have accumulated since the 1990s, resulting in much interesting evidence related to natural product research using monoclonal antibodies. In this context, this Special Issue encourages the discussion of new research in the field of natural products. Colleagues in the field of natural products are invited to contribute their work discussing and debating natural product research.
Prof. Dr. Yukihiro Shoyama
Prof. Dr. Hiroyuki Tanaka
Dr. Seiichi Sakamoto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Monoclonal antibodies
- Small molecule natural product
- Development and application
- Qualitative and quantitative analysis
- Analytical kit
- Affinity column
- Affinity isolation
- Compact antibody
- Single-chain Fv
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.